Dr Reddys Laboratories, an integrated global pharmaceutical company, witnessed a fall in share prices on Wednesday after reporting weak set of quarterly earnings. The company has reported a fall of 16.81% in its consolidated net profit for the second quarter. It earned profit of Rs 5.74 billion for the quarter ended Sept. 30, 2014 compared with Rs 6.90 billion, a year ago.
Net income came at Rs 35.88 billion, an increase of 6.88% over Rs 33.57 billion in the same period a year ago.
Shares of the company are trading at Rs 3,021, down Rs 59.65, or 1.94% at the Bombay Stock Exchange (BSE) on Wednesday at 2:55 p.m.
The scrip has touched an intra-day high of Rs 3,117.30 and low of Rs 2,996. The total volume of shares traded at the BSE is 57,163.